Home Merck, Iowa firm sign Ebola vaccine licensing deal
 

Keywords :   


Merck, Iowa firm sign Ebola vaccine licensing deal

2014-11-24 20:15:55| Biotech - Topix.net

Merck & Co., one of the world's top developers and sellers of vaccines, has entered a partnership with a small drug developer to research and manufacture a potential Ebola vaccine now in initial patient testing. The exclusive deal involves a vaccine candidate called rVSV-EBOV that's under early development by BioProtection Systems, the vaccine-development subsidiary of NewLink Genetics Corp. of Ames, Iowa.

Tags: sign deal firm iowa

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
04.07Eastern North Pacific Tropical Weather Outlook
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Public Advisory Number 23A
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Eastern North Pacific Tropical Weather Outlook
04.07Atlantic Tropical Weather Outlook
04.07K-State hosts African swine fever mitigation workshop
04.07EU hits Chinese electric cars with steep tariffs
More »